← Browse by Condition
Medical Condition
progression
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3, Phase 2
ClinicalMetric tracks all active clinical trials for progression sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 2
Phase 3 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
NCT07008716 Phase 3
Recruiting
Omitting CTV for Primary Tumor in LS-SCLC
Enrollment
852 pts
Location
China
Sponsor
Sun Yat-sen University
NCT04905056 Phase 2
Recruiting
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
Enrollment
120 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
NCT05791630
Recruiting
The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)
Enrollment
23,650 pts
Location
Norway
Sponsor
Ostfold Hospital Trust
NCT06472388 Phase 2
Recruiting
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Enrollment
100 pts
Location
Brazil
Sponsor
AC Camargo Cancer Center
NCT04581122
Recruiting
A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components
Enrollment
1,500 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology